Handel nachbörslich: 205.79

Charles River Laboratories International Inc (CRL)

Charles River Laboratories International Inc Aktie (CRL) Neueste Nachrichten

Charles River Laboratories International Inc (CRL)

Charles River Laboratories International Inc Aktie (CRL) Neueste Nachrichten

Charles River Laboratories International (NYSE:CRL) Given New $190.00 Price Target at Robert W. Baird - MarketBeat

Cell & Gene Therapy Manufacturing Services Market Size, Opportunities, and Growth Strategies 2024-2033 - WhaTech

For the first time in four years, the Charles River experiences a cyanobacteria bloom - Boston 25 News

What is Charles River Laboratories International Inc. (CRL) Stock Return on Shareholders’ Capital? - SETE News

Envestnet Asset Management Inc. Raises Stake in Charles River Laboratories International, Inc. (NYSE:CRL) - MarketBeat

Envestnet Asset Management Inc. Buys 11,514 Shares of Charles River Laboratories International, Inc. (NYSE:CRL) - Defense World

Ori Biotech and Charles River Laboratories Collaborate to - GlobeNewswire

CRL Stock to Gain From Strategic Neuroscience Partnership With CEBINA - Yahoo Finance

Ori doubles down on Charles River collaboration with promising new data on its automated cell therapy platform - FiercePharma

16,725 Shares in Charles River Laboratories International, Inc. (NYSE:CRL) Bought by Edgestream Partners L.P. - MarketBeat

Pediatric Clinical Trials Market Future Business - openPR

Robert W. Baird downgrades Charles River Laboratories International Inc. (CRL) stock to a Neutral - Knox Daily

Charles River Laboratories International, Inc. (NYSE:CRL) Shares Sold by Dai ichi Life Insurance Company Ltd - MarketBeat

Mizuho highlights cost-saving focus amid challenges for Charles River stock - Investing.com

Charles River teams up with CEBINA for neurodegeneration - Investing.com

Charles River teams up with CEBINA for neurodegeneration By Investing.com - Investing.com Canada

Charles River teams up with CEBINA for neurodegeneration By Investing.com - Investing.com Australia

Mizuho highlights cost-saving focus amid challenges for Charles River stock - Investing.com Australia

Forsta AP Fonden Lowers Stake in Charles River Laboratories International, Inc. (NYSE:CRL) - Defense World

Charles River teams up with CEBINA for neurodegeneration - Investing.com India

Charles River teams up with CEBINA for neurodegeneration By Investing.com - Investing.com UK

Mizuho highlights cost-saving focus amid challenges for Charles River stock - Investing.com Canada

Charles River Laboratories and CEBINA Announce Strategic Collaboration to Accelerate Cutting Edge Neuroscience Research - StockTitan

Global firm with North Carolina operations to lay off hundreds - The Business Journals

Biopharma Layoff Tracker 2024: Oncternal, Biosense Webster, Charles River Laboratories and More Cut Staff - BioSpace

Charles River Laboratories International, Inc. (NYSE:CRL) Shares Acquired by Oppenheimer Asset Management Inc. - MarketBeat

Wedbush Securities Inc. Has $271,000 Stock Holdings in CRH plc (NYSE:CRH) - Defense World

Charles River Labs to cut over 600 jobs - The Boston Globe

Charles River Labs to lay off 650 employees - NBC Boston

Charles River Labs to lay off 650 workers in 2024 - The Business Journals

Cell-Based Assays Market Size to Grow at 6.4% CAGR and Surpass USD 40.4 Billion by 2034 Amid Rising Research Applications | According to Transparency Market Research Inc. - GlobeNewswire Inc.

Quest Partners LLC Raises Position in Charles River Laboratories International, Inc. (NYSE:CRL) - MarketBeat

Why Charles River Laboratories International, Inc. (NYSE:CRL) Could Be Worth Watching - Simply Wall St

Mawer Investment Management Ltd. Grows Position in Charles River Laboratories International, Inc. (NYSE:CRL) - MarketBeat

Charles River Laboratories International, Inc. (NYSE:CRL) Receives Average Recommendation of "Hold" from Analysts - MarketBeat

Van Berkom & Associates Inc. Grows Stock Position in Charles River Laboratories International, Inc. (NYSE:CRL) - MarketBeat

CRL Stock May Benefit From New Neuroscience Research Collaboration - Yahoo Finance

Anchor Capital Advisors LLC Sells 4,599 Shares of Charles River Laboratories International, Inc. (NYSE:CRL) - MarketBeat

Charles River Laboratories International, Inc. (NYSE:CRL) Shares Sold by Principal Financial Group Inc. - MarketBeat

Charles River Laboratories International (CRL) Fell Due to a More Cautious Funding Environment - MSN

Jensen Investment Management Inc. Trims Holdings in Charles River Laboratories International, Inc. (NYSE:CRL) - MarketBeat

Why Is Charles River (CRL) Down 5.3% Since Last Earnings Report? - Yahoo Finance

Higher Interest Environment Negatively Impacted Charles River Laboratories (CRL) - Insider Monkey

Higher Interest Environment Negatively Impacted Charles River Laboratories (CRL) - Yahoo Finance

CRL INVESTIGATION ALERT: Johnson Fistel LLP Investigates - GlobeNewswire

CRL INVESTIGATION ALERT: Johnson Fistel LLP Investigates Charles River Laboratories’ Directors and Officers - EIN News

$6.1 Bn Vaccine Contract Manufacturing Market by Vaccine Type, Workflow, Application, and Region 2024-2032 - GlobeNewswire Inc.

Global Viral Inactivation Market Size To Worth USD 1915.2 Million By 2033 | CAGR Of 11.35% - GlobeNewswire Inc.

Charles River, Insightec partner on neuroscience drug delivery - Investing.com

Mesirow Institutional Investment Management Inc. Purchases New Holdings in Charles River Laboratories International, Inc. (NYSE:CRL) - MarketBeat

Charles River and Insightec Announce Strategic Collaboration to Advance Therapeutic Development Utilizing Focused Ultrasound in Neuroscience - sharewise

Charles River, Insightec partner on neuroscience drug delivery By Investing.com - Investing.com Canada

Charles River and Insightec Announce Strategic Collaboration to Advance Therapeutic Development Utilizing Focused Ultrasound in Neuroscience - ShareCast

Charles River and Insightec Announce Strategic Collaboration to Advance Therapeutic Development Utilizing Focused Ultrasound in Neuroscience - PR Newswire

Charles River and Insightec Announce Strategic Collaboration to Advance Therapeutic Development Utilizing Focused Ultrasound in Ne - Börse Express

Charles River and Insightec Announce Strategic Collaboration to Advance Therapeutic Development Utilizing Focused Ultrasound in Neuroscience - PR Newswire UK

Charles River and Insightec Announce Strategic Collaboration to Advance Therapeutic Development Utilizing Focused Ultrasound in Neuroscience - Yahoo Finance

Physical, Engineering, And Life Sciences Market Innovations Investigated by Size, Share, Growth Analysis an... - WhaTech

Charles River Laboratories to Present at Baird and Morgan Stanley Conferences - sharewise.com

Charles River Laboratories to Present at Baird and Morgan Stanley Conferences - Yahoo Finance UK

Charles River Laboratories to Present at Baird and Morgan Stanley Conferences - Yahoo Finance

Versor Investments LP Buys Shares of 5,740 Charles River Laboratories International, Inc. (NYSE:CRL) - MarketBeat

Charles River Laboratories to Present at Baird and Morgan Stanley Conferences - StockTitan

Charles River Laboratories International, Inc. Forecasted to Earn Q3 2024 Earnings of $2.44 Per Share (NYSE:CRL) - MarketBeat

Hantz Financial Services Inc. Takes $7.87 Million Position in Charles River Laboratories International, Inc. (NYSE:CRL) - MarketBeat

Calculating The Intrinsic Value Of Charles River Laboratories International, Inc. (NYSE:CRL) - Yahoo Finance

Q1 2025 Earnings Estimate for Charles River Laboratories International, Inc. Issued By Zacks Research (NYSE:CRL) - MarketBeat

Charles River Laboratories International, Inc. (NYSE:CRL) Shares Purchased by Bank of New York Mellon Corp - MarketBeat

Charles River Laboratories International (CRL) Fell Due to a More Cautious Funding Environment - Insider Monkey

Ähnlich wie CRL